| Issue Date |
Title |
Author(s) |
| 2014 |
An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia |
Huang, Xinfang;Du, Hui;Gu, Jieruo;Zhao, Dongbao;Jiang, Lindi;Li, Xinfu;Zuo, Xiaoxia;Liu, Yi;Li, Zhanguo;Li, Xiangpei;Zhu, Ping;Li, Juan;Zhang, Zhiyi;Huang, Anbin;Zhang, Yuanchao;Bao, Chunde |
| 2019 |
Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians |
Molineros, Julio E.;Looger, Loren L.;Kim, Kwangwoo;Okada, Yukinori;Terao, Chikashi;Sun, Celi;Zhou, Xu-jie;Raj, Prithvi;Kochi, Yuta;Suzuki, Akari;Akizuki, Shuji;Nakabo, Shuichiro;Bang, So-Young;Lee, Hye-Soon;Kang, Young Mo;Suh, Chang-Hee;Chung, Won Tae;Park, Yong-Beom;Choe, Jung-Yoon;Shim, Seung-Cheol;Lee, Shin-Seok;Zuo, Xiaoxia;Yamamoto, Kazuhiko;Li, Quan-Zhen;Shen, Nan;Porter, Lauren L.;Harley, John B.;Chua, Kek Heng;Zhang, Hong;Wakeland, Edward K.;Tsao, Betty P.;Bae, Sang-Cheol;Nath, Swapan K. |
| 2019 |
Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study |
An, Yuan;Zhou, Yunshan;Bi, Liqi;Liu, Bo;Wang, Hong;Lin, Jin;Xu, Danyi;Wang, Mei;Zhang, Jing;Wang, Yongfu;An, Yan;Zhu, Ping;Xie, Ronghua;Zhang, Zhiyi;Mei, Yifang;Liu, Xiangyuan;Deng, Xiaoli;Yao, Zhongqiang;Zhang, Zhuoli;Wang, Yu;Xiao, Weiguo;Shen, Hui;Yang, Xiuyan;Xu, Hanshi;Yu, Feng;Wang, Guochun;Lu, Xin;Li, Yang;Li, Yingnan;Zuo, Xiaoxia;Li, Yisha;Liu, Yi;Zhao, Yi;Guo, Jianping;Sun, Lingyun;Zhao, Minghui;Li, Zhanguo |
| Jun-2020 |
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial |
Su, Jinmei;Li, Mengtao;He, Lan;Zhao, Dongbao;Wan, Weiguo;Liu, Yi;Xu, Jianhua;Xu, Jian;Liu, Huaxiang;Jiang, Lindi;Wu, Huaxiang;Zuo, Xiaoxia;Huang, Cibo;Liu, Xiumei;Li, Fen;Zhang, Zhiyi;Liu, Xiangyuan;Dong, Lingli;Li, Tianwang;Chen, Haiying;Li, Jingyang;He, Dongyi;Lu, Xin;Huang, Anbin;Tao, Yi;Wang, Yanyan;Zhang, Zhuoli;Wei, Wei;Li, Xiaofeng;Zeng, Xiaofeng |
| 2018 |
Develop a Master Algorithm for Drug Withdraw Strategy in Reduction of Adverse Events - a Machine Learning Model from the Smart System of Disease Management (SSDM) |
Zhao, Yan;Yang, Jing;Huang, Jianlin;Wei, Hua;Wang, Yongfu;Mu, Rong;Zuo, Xiaoxia;Wang, Hongzhi;Duan, Xinwang;Xue, Jing;Sun, Hongsheng;Wu, Bin;Kang, Lirong;Wei, Feng;Mi, Cundong;Zhao, Yanping;Li, Yang;Chen, Haiying;Li, Zhenbin;Meng, Qingliang;Jia, Yuhua;Xiao, Hui;Xiao, Fei |
| May-2021 |
Exome-Wide Association Analysis Suggests LRP2BP as a Susceptibility Gene for Endothelial Injury in Systemic Sclerosis in the Han Chinese |
Pu, Weilin;Wu, Wenyu;Liu, Qingmei;Ma, Yanyun;Tu, Wenzhen;Zuo, Xianbo;Guo, Gang;Jiang, Shuai;Zhao, Yinhuan;Zuo, Xiaoxia;Wang, Qingwen;Yang, Li;Xiao, Rong;Chu, Haiyan;Wang, Lei;Sun, Liangdan;Cui, Jimin;Yu, Ling;Li, Huiyun;Li, Yisha;Shi, Yaqian;Zhang, Jiaqian;Zhang, Haishun;Liang, Minrui;Chen, Dongdong;Ding, Yue;Chen, Xiangxiang;Chen, Yuanyuan;Zhang, Rui;Zhao, Han;Li, Yuan;Qi, Qing;Bai, Peng;Zhao, Liang;Reveille, John D.;Mayes, Maureen D.;Jin, Li;Lee, Eun Bong;Zhang, Xuejun;Xu, Jinhua;Zhang, Zheng;Zhou, Xiaodong;Zou, Hejian;Wang, Jiucun |
| 2013 |
A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23 |
Li, Yongzhe;Zhang, Kunlin;Chen, Hua;Sun, Fei;Xu, Juanjuan;Wu, Ziyan;Li, Ping;Zhang, Liuyan;Du, Yang;Luan, Haixia;Li, Xi;Wu, Lijun;Li, Hongbin;Wu, Huaxiang;Li, Xiangpei;Li, Xiaomei;Zhang, Xiao;Gong, Lu;Dai, Lie;Sun, Lingyun;Zuo, Xiaoxia;Xu, Jianhua;Gong, Huiping;Li, Zhijun;Tong, Shengquan;Wu, Min;Li, Xiaofeng;Xiao, Weiguo;Wang, Guochun;Zhu, Ping;Shen, Min;Liu, Shengyun;Zhao, Dongbao;Liu, Wei;Wang, Yi;Huang, Cibo;Jiang, Quan;Liu, Guijian;Liu, Bin;Hu, Shaoxian;Zhang, Wen;Zhang, Zhuoli;You, Xin;Li, Mengtao;Hao, |
| Jan-2022 |
LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis |
Shi, Xiangguang;Chen, Yahui;Liu, Qingmei;Mei, Xueqian;Liu, Jing;Tang, Yulong;Luo, Ruoyu;Sun, Dayan;Ma, Yanyun;Wu, Wenyu;Tu, Wenzhen;Zhao, Yinhuan;Xu, Weihong;Ke, Yuehai;Jiang, Shuai;Huang, Yan;Zhang, Rui;Wang, Lei;Chen, Yuanyuan;Xia, Jingjing;Pu, Weilin;Zhu, Honglin;Zuo, Xiaoxia;Li, Yisha;Xu, Jinhua;Gao, Fei;Wei, Dong;Chen, Jingyu;Yin, Wenguang;Wang, Qingwen;Dai, Huaping;Yang, Libing;Guo, Gang;Cui, Jimin;Song, Nana;Zou, Hejian;Zhao, Shimin;Distler, Jorg H. W.;Jin, Li;Wang, Jiucun |
| 2019 |
Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study |
Qian, Junyan;Li, Mengtao;Zhang, Xiao;Wang, Qian;Zhao, Jiuliang;Tian, Zhuang;Wei, Wei;Zuo, Xiaoxia;Zhang, Miaojia;Zhu, Ping;Ye, Shuang;Zhang, Wei;Zheng, Yi;Qi, Wufang;Li, Yang;Zhang, Zhuoli;Ding, Feng;Gu, Jieruo;Liu, Yi;Wang, Yanhong;Zeng, Xiaofeng |
| 2016 |
miR-146b expression is upregulated in the lung of pulmonary fibrosis mice |
Chai, Jing;Li, Zhihong;Zhou, Bin;Zhu, Honglin;Xie, Xiaoyun;Zuo, Xiaoxia |
| 2019 |
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO SEVERE PA |
Zeng, Xiaofeng;Wang, Yongfu;Jiang, Zhenyu;Zhang, Zhuoli;He, Lan;Zhang, Xiao;Lu, Xin;Liu, Xiumei;Xu, Jian;Huang, Cibo;Liu, Rui;Zuo, Xiaoxia;Zhao, Baozeng;Qiu, Wenting;Chai, Katherine;Guo, Xinjun;Zhang, Xin;Liu, Eugene;Luk, Alvin;Jiang, Weidong;Liu, Scott;Hu, Pei;Chen, Xia |
| 2014 |
Novel Risk Loci for Rheumatoid Arthritis in Han Chinese and Congruence With Risk Variants in Europeans |
Jiang, Lei;Yin, Jian;Ye, Lingying;Yang, Jian;Hemani, Gibran;Liu, Ai-Jun;Zou, Hejian;He, Dongyi;Sun, Lingyun;Zeng, Xiaofeng;Li, Zhanguo;Zheng, Yi;Lin, Yiping;Liu, Yi;Fang, Yongfei;Xu, Jianhua;Li, Yinong;Dai, Shengming;Guan, Jianlong;Jiang, Lindi;Wei, Qianghua;Wang, Yi;Li, Yang;Huang, Cibo;Zuo, Xiaoxia;Liu, Yu;Wu, Xin;Zhang, Libin;Zhou, Ling;Zhang, Qing;Li, Ting;Chen, Ling;Xu, Zhen;Yang, Xiaoping;Qian, Feng;Xie, Weilin;Liu, Wei;Guo, Qian;Huang, Shaolan;Zhao, Jing;Li, Mengmeng;Jin, Yanhua;Gao, Jie;Lv, Ying;Wan |
| 2019 |
Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors |
Zhang, Na;Li, Mengtao;Qian, Junyan;Wang, Qian;Zhao, Jiuliang;Yang, Zhenwen;Tian, Zhuang;Zhang, Xiao;Zuo, Xiaoxia;Zhang, Miaojia;Zhu, Ping;Ye, Shuang;Zhang, Wei;Zheng, Yi;Qi, Wufang;Li, Yang;Zhang, Zhuoli;Ding, Feng;Gu, Jieruo;Liu, Yi;Wei, Wei;Zeng, Xiaofeng |
